CIK 0000920148
- Large accelerated filer
LABCORP HOLDINGS INC.
Sign in to watch- Ticker
- LH
- Exchange
- NYSE
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 992588107
- Phone
- +1 336-229-1127
- Business address
- 358 S MAIN ST, BURLINGTON, NC, 27215
- Former names
- LABORATORY CORP OF AMERICA HOLDINGS, NATIONAL HEALTH LABORATORIES HOLDINGS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,377,699
- in 4 filings, $108K under 10b5-1 plans
Net −$1,377,699. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-11 | Summy Amy B. EVP, Chief Marketing Officer | Exercise or conversion | +201 | 4,152 | ||
| 2024-02-11 | Summy Amy B. EVP, Chief Marketing Officer | Exercise or conversion · Restricted Stock Unit | −201 | 7,095 | ||
| 2024-02-11 | van der Vaart Sandra D EVP, Chief Legal Officer | Exercise or conversion | +324 | 7,960.98 | ||
| 2024-02-11 | van der Vaart Sandra D EVP, Chief Legal Officer | Exercise or conversion · Restricted Stock Unit | −324 | 8,348 | ||
| 2024-02-11 | Wilkinson Peter J SVP, Chief Accounting Officer | Exercise or conversion | +123 | 2,384.22 | ||
| 2024-02-11 | Wilkinson Peter J SVP, Chief Accounting Officer | Exercise or conversion · Restricted Stock Unit | −123 | 3,870 | ||
| 2024-02-08 | van der Vaart Sandra D EVP, Chief Legal Officer | Sale 10b5-1 | −259 | $222.06 | $58K | 7,636.98 |
| 2024-02-07 | Schechter Adam H President & CEO | Exercise or conversion | +3,250 | 52,410 | ||
| 2024-02-07 | Schechter Adam H President & CEO | Shares withheld for taxes | −1,149 | $223.71 | $257K | 51,261 |
| 2024-02-07 | Schechter Adam H President & CEO | Exercise or conversion · Restricted Stock Unit | −3,250 | 98,241 | ||
| 2024-02-07 | EISENBERG GLENN A Chief Financial Officer, EVP | Exercise or conversion | +885 | 43,689 | ||
| 2024-02-07 | EISENBERG GLENN A Chief Financial Officer, EVP | Shares withheld for taxes | −236 | $223.71 | $53K | 43,453 |
| 2024-02-07 | EISENBERG GLENN A Chief Financial Officer, EVP | Exercise or conversion · Restricted Stock Unit | −885 | 36,546 | ||
| 2024-02-07 | DiVincenzo Jonathan P. EVP, Pres, Central Labs & Intl | Exercise or conversion | +224 | 3,739.55 | ||
| 2024-02-07 | DiVincenzo Jonathan P. EVP, Pres, Central Labs & Intl | Shares withheld for taxes | −78 | $223.71 | $17K | 3,661.55 |
| 2024-02-07 | DiVincenzo Jonathan P. EVP, Pres, Central Labs & Intl | Exercise or conversion | +138 | 3,799.55 | ||
| 2024-02-07 | DiVincenzo Jonathan P. EVP, Pres, Central Labs & Intl | Shares withheld for taxes | −41 | $223.71 | $9K | 3,758.55 |
| 2024-02-07 | DiVincenzo Jonathan P. EVP, Pres, Central Labs & Intl | Exercise or conversion · Restricted Stock Unit | −224 | 5,316 | ||
| 2024-02-07 | DiVincenzo Jonathan P. EVP, Pres, Central Labs & Intl | Exercise or conversion · Restricted Stock Unit | −138 | 5,178 | ||
| 2024-02-07 | Caveney Brian J EVP, Pres of ED, CMO & CSO | Exercise or conversion | +517 | 21,143.04 |
Page 29 of 41 · 816 trades